Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Clinical trial NCT04738162 · COMPLETED

Trial details

NCT number: NCT04738162
Sponsor: Universität Münster
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Tumor, Pediatric

Start date: 2020-09-25
Primary completion: 2025-11-24
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.